Publication: Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia
| dc.contributor.coauthor | Ho, S. | |
| dc.contributor.coauthor | Wong, H. K. | |
| dc.contributor.coauthor | Shqau, D. | |
| dc.contributor.coauthor | Winklmeier, S. | |
| dc.contributor.coauthor | Grobe-Einsler, M. | |
| dc.contributor.coauthor | Rostasy, K. | |
| dc.contributor.coauthor | Kümpfel, T. | |
| dc.contributor.coauthor | Thaler, F. S. | |
| dc.contributor.coauthor | Brimberg, L. | |
| dc.contributor.coauthor | Schneider, M. A. | |
| dc.contributor.coauthor | Muley, T. | |
| dc.contributor.coauthor | Seifert-Held, T. | |
| dc.contributor.coauthor | Endmayr, V. | |
| dc.contributor.coauthor | Höftberger, R. | |
| dc.contributor.coauthor | Faber, J. | |
| dc.contributor.coauthor | Klopstock, T. | |
| dc.contributor.coauthor | Frahm, S. | |
| dc.contributor.coauthor | Gerdes, L. A. | |
| dc.contributor.coauthor | Meinl, E. | |
| dc.contributor.coauthor | Mader, S. | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
| dc.contributor.department | Graduate School of Health Sciences | |
| dc.contributor.kuauthor | Vural, Atay | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.contributor.schoolcollegeinstitute | GRADUATE SCHOOL OF HEALTH SCIENCES | |
| dc.contributor.schoolcollegeinstitute | Research Center | |
| dc.date.accessioned | 2026-07-17T08:30:13Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Cerebellar ataxias (CAs) encompass a wide spectrum of genetic and sporadic origins, of which a portion is driven by immune-mediated pathomechanisms. While some patients harbor known autoantibodies, assisting diagnosis and treatment, many remain seronegative. Here, we identify synaptophysin (SYP) as an autoantigen in CA by serum IgG staining on primate tissue, combined with human protein array and cell-based assay (CBA). SYP is abundant in presynaptic vesicles and is transiently exposed on the cell surface. Out of 43 patients with CA with synaptic serum reactivity on cerebellar sections, SYP antibodies were identified by CBA in 2 patients. Exposure of human induced pluripotent stem cell (iPSC)-derived glutamatergic neurons to patient’s IgG with SYP antibodies causes selective SYP accumulation at the presynaptic membrane. Patient’s IgG and SYP monoclonal antibody reduce neuronal populational activity recorded by multi-electrode array. Altogether, we identify SYP as an autoantigen for further stratifying patients with CA. Our functional experiments with SYP antibodies uncover a previously unrecognized mechanism of antibody-mediated synaptic dysfunction. | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.sponsorship | This study has been enabled by the following: the Else Kroner-Fresenius-Stiftung (to S.M.), the Schering Stiftung and the Fritz Thyssen Foundation (to S.M.), the National Ataxia Foundation (to S.M.), the DFG (SFB TR128 and ME 1509/2-1 to E.M.), the Verein zurTherapieforschung fur MS Kranke (to E.M.), the Austrian Science Fund FWF SYNABS I6565-B (R.H.), Forschungsforderungsgesellschaft FFG IGNITEMIND FO999920011 (R.H.), and the Austrian Society of Neurology (Osterreichische Gesellschaft fur Neurologie) (R.H., T.S-H.). The authors would like to thank Betty Diamond, Sabine Liebscher, and Florence Bareyre for comments on the manuscript. The authors gratefully acknowledge access to clinically uncharacterized serum samples with granular layer staining pattern of unknown reactivity by the Mayo Clinic Neuroimmunology Laboratory. The authors gratefully acknowledge access to the longitudinal, multi-center cohort of consecutive patients with sporadic adult-onset ataxia (SPORTAX), as well as the samples and data provided by the Lung Biobank Heidelberg, part of the Biomaterial Bank Heidelberg (BMBH), and all participating centers that contributed samples to this study, as well as all patients involved. The authors would liketo thank Mike Cousin and Hisashi Umemori for providing the mCer-hSYP and rSYP-YFP plasmids, respectively. The authors are grateful to the Technology Platform Pluripotent Stem Cells of the Max Delbruck Center for providing the BIHi005-A-24 line and fortheir support with the MEA experiments. The authors are verygrateful to bit.bio for their generous support and expertise in the human iPSC-derived glutamatergic neurons. The authors would also like to extend their gratitude to PEPperPRINT for their continued support and to Ivanela Kondova for providing rhesus tissue blocks essential for establishment of assays, as well as Andree Schmidt for assistance during antigen identification. Furthermore, the authors would like to thank Andreas Thomae and Jan Brocher for valuable advice on image analyses and Tobias Straub and Yemil Atisha-Fregoso for statistical expertise. The authors are grateful to Stefan Lichtenthaler and Eric Chang for valuable discussions. Finally, the authors appreciate the technical support by Christian Lad, Yaren Canten, Ceren Ozdemir, Elif Donmez, and the clinical staffs at the outpatient clinic of the Institute of Clinical Neuroimmuniology of LMU Munich. | |
| dc.description.version | Published Version | |
| dc.identifier.ScopusPercentile | 97 | |
| dc.identifier.ScopusQuartile | Q1 | |
| dc.identifier.WoSPercentile | 94.0 | |
| dc.identifier.WoSQuartile | Q1 | |
| dc.identifier.doi | 10.1016/j.xcrm.2026.102822 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.issn | 2666-3791 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pubmed | 42155449 | |
| dc.identifier.scopus | 2-s2.0-105041689308 | |
| dc.identifier.uri | http://doi.org/10.1016/j.xcrm.2026.102822 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/33505 | |
| dc.identifier.volume | 7 | |
| dc.identifier.wos | 001801568400002 | |
| dc.keywords | Autoantibodies | |
| dc.keywords | Synaptophysin | |
| dc.keywords | Cerebellar ataxia | |
| dc.keywords | Neuroinflammation | |
| dc.keywords | Autoimmunity | |
| dc.keywords | Synapse | |
| dc.language | eng | |
| dc.publisher | Elsevier | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Cell Reports Medicine | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.rights.uri | N/A | |
| dc.subject | Cell biology | |
| dc.title | Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia | |
| dc.type | Journal Article | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
| relation.isOrgUnitOfPublication | 2f870f28-12c9-4b28-9465-b91a69c1d48c | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication | 4c75e0a5-ca7f-4443-bd78-1b473d4f6743 | |
| relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
